These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27272)

  • 1. Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.
    Tyers MB
    Br J Pharmacol; 1978 Jun; 63(2):287-93. PubMed ID: 27272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on fazadinium bromide (ah 8165): a new non-depolarizing neuromuscular blocking agent.
    Hughes R; Payne JP; Sugai N
    Can Anaesth Soc J; 1976 Jan; 23(1):36-47. PubMed ID: 2378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of fazadinium.
    Bevan DR; D'Souza J; Rouse JM; Caldwell J; Smith RL
    Anaesthesia; 1980 Sep; 35(9):873-8. PubMed ID: 6108730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between decay of plasma concentration of fazadinium and recovery from its neuromuscular blocking effect.
    d'Hollander AA; Duvaldestin P; Henzel D; Delcroix C; Desmonts JM
    Br J Anaesth; 1981 Aug; 53(8):853-8. PubMed ID: 6115662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of single twitch and train-of-four responses and of tetanic fade in relation to plasma concentrations of fazadinium in man.
    d'Hollander AA; Duvaldestin P; Delcroix C; Nevelsteen M; Desmonts JM
    Anesth Analg; 1982 Mar; 61(3):225-30. PubMed ID: 6121521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fazadinium and pancuronium: a pharmacodynamic study.
    Hull CJ; English MJ; Sibbald A
    Br J Anaesth; 1980 Dec; 52(12):1209-21. PubMed ID: 6108777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of speed of onset of fazadinium, pancuronium, tubocurarine and suxamethonium.
    Blackburn CL; Morgan M
    Br J Anaesth; 1978 Apr; 50(4):361-4. PubMed ID: 26369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blocking potency of fazadinium in man.
    Hashimoto Y; Shima T; Matsukawa S; Satou M
    Anaesthesia; 1979 Jan; 34(1):10-3. PubMed ID: 34334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pharmacokinetics and pharmacodynamics of fazadinium in rabbits.
    Dominguez-Gil AA; Cepeda M; Muriel C; Calvo JI; Dominguez-Gil A; Alonso AC
    Arzneimittelforschung; 1981; 31(11):1913-7. PubMed ID: 6119095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of fazadinium in patients with renal failure.
    Duvaldestin P; Bertrand JC; Concina D; Henzel D; Lareng L; Desmonts JM
    Br J Anaesth; 1979 Oct; 51(10):943-7. PubMed ID: 42420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.
    Bevan DR; D'Souza JD; Rouse JM; Caldwell J; Smith RL
    Eur J Clin Pharmacol; 1981; 20(4):293-8. PubMed ID: 6118278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative potency and speed of onset of fazadinium and d-tubocurarine.
    Hussain SZ; Healy TE; Birmingham AT
    Acta Anaesthesiol Scand; 1979 Aug; 23(4):331-5. PubMed ID: 40380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of fazadinium in children. An electromyographic study.
    Esener Z
    Br J Anaesth; 1983 Dec; 55(12):1205-12. PubMed ID: 6140023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of fazadinium in man.
    Duvaldestin P; Henzel D; Demetriou M; Desmonts JM
    Br J Anaesth; 1978 Aug; 50(8):773-7. PubMed ID: 28133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blockade of fazadinium bromide (AH 8165) in renal failure patients.
    Camu F; D'Hollander A
    Acta Anaesthesiol Scand; 1978; 22(3):221-6. PubMed ID: 27936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.
    d'Hollander AA; Delcroix C; Duvaldestin P; Henzel D; Coussaert E; Desmonts JM
    Eur J Clin Pharmacol; 1983; 24(3):407-13. PubMed ID: 6134623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of recovery from fazadinium: relationship to the rate of decline of its plasma concentration.
    Ramzan IM
    J Pharm Sci; 1983 Nov; 72(11):1369-70. PubMed ID: 6139474
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of fazadinium on respiratory functions and its correlation with neuromuscular transmission in children.
    Esener Z
    Middle East J Anaesthesiol; 1987 Feb; 9(1):97-107. PubMed ID: 2886900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromuscular block induced by fazadinium. Electrophysiological study on fast and slow muscles in the rabbit].
    Dattola R; Praticò C; Girlanda P; Vita G; Venuto C; Venuti FS; Montanini S; Messina C
    Minerva Anestesiol; 1984; 50(7-8):379-82. PubMed ID: 6151630
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.